A078160 Stock Overview
Engages in the cord blood bank business in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
MEDIPOST Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩11,520.00 |
| 52 Week High | ₩15,180.00 |
| 52 Week Low | ₩5,450.00 |
| Beta | 0.37 |
| 1 Month Change | 26.45% |
| 3 Month Change | 102.82% |
| 1 Year Change | 41.18% |
| 3 Year Change | -46.67% |
| 5 Year Change | -65.46% |
| Change since IPO | -44.35% |
Recent News & Updates
MEDIPOST Co., Ltd. (KOSDAQ:078160) Stock Rockets 61% As Investors Are Less Pessimistic Than Expected
Dec 19
Health Check: How Prudently Does MEDIPOST (KOSDAQ:078160) Use Debt?
Dec 10Recent updates
MEDIPOST Co., Ltd. (KOSDAQ:078160) Stock Rockets 61% As Investors Are Less Pessimistic Than Expected
Dec 19Health Check: How Prudently Does MEDIPOST (KOSDAQ:078160) Use Debt?
Dec 10Subdued Growth No Barrier To MEDIPOST Co., Ltd. (KOSDAQ:078160) With Shares Advancing 29%
Nov 04Is MEDIPOST (KOSDAQ:078160) Using Debt Sensibly?
Aug 06MEDIPOST's (KOSDAQ:078160) Attractive Earnings Are Not All Good News For Shareholders
Mar 27Is MEDIPOST (KOSDAQ:078160) Weighed On By Its Debt Load?
Mar 11MEDIPOST's (KOSDAQ:078160) Stock Price Has Reduced 32% In The Past Three Years
Jan 17Is MEDIPOST (KOSDAQ:078160) A Risky Investment?
Nov 24Shareholder Returns
| A078160 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | -6.4% | 2.1% | -1.5% |
| 1Y | 41.2% | -23.9% | -12.2% |
Return vs Industry: A078160 exceeded the KR Healthcare industry which returned -26% over the past year.
Return vs Market: A078160 exceeded the KR Market which returned -12.2% over the past year.
Price Volatility
| A078160 volatility | |
|---|---|
| A078160 Average Weekly Movement | 15.6% |
| Healthcare Industry Average Movement | 10.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A078160's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A078160's weekly volatility has increased from 9% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 308 | n/a | www.medi-post.co.kr |
MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name.
MEDIPOST Co., Ltd. Fundamentals Summary
| A078160 fundamental statistics | |
|---|---|
| Market cap | ₩392.82b |
| Earnings (TTM) | -₩10.82b |
| Revenue (TTM) | ₩69.86b |
5.6x
P/S Ratio-36.3x
P/E RatioIs A078160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A078160 income statement (TTM) | |
|---|---|
| Revenue | ₩69.86b |
| Cost of Revenue | ₩27.54b |
| Gross Profit | ₩42.32b |
| Other Expenses | ₩53.14b |
| Earnings | -₩10.82b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -317.22 |
| Gross Margin | 60.58% |
| Net Profit Margin | -15.48% |
| Debt/Equity Ratio | 3.1% |
How did A078160 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:13 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MEDIPOST Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nam Park | HSBC |
| Al Eum Lee | iM Securities |
| Sangpyo Kim | Kiwoom Securities Co., Ltd. |